Madrigal Pharmaceuticals, Inc.

ROYAL BANK OF CANADA MDGL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

10,223

Value ($000)

5,953

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	5,953	0.0%	10,223	12/31/2025
2025 Q2	8/14/2025	2,906	0.0%	9,603	6/30/2025
2025 Q1	11/21/2025	2,921	0.0%	8,819	3/31/2025
2024 Q4	2/14/2025	3,515	0.0%	11,390	12/31/2024
2024 Q3	11/14/2024	2,046	0.0%	9,648	9/30/2024
2024 Q2	11/6/2024	2,347	0.0%	8,375	6/30/2024
2024 Q1	11/5/2024	671	0.0%	2,511	3/31/2024
2023 Q4	2/14/2024	1,553	0.0%	6,715	12/31/2023
2023 Q3	11/14/2023	324	0.0%	2,222	9/30/2023
2023 Q2	8/14/2023	2,630	0.0%	11,388	6/30/2023
2023 Q1	5/15/2023	3,143	0.0%	12,971	3/31/2023
2022 Q4	2/14/2023	3,817	0.0%	13,150	12/31/2022
2022 Q3	11/14/2022	688	0.0%	10,580	9/30/2022
2022 Q2	8/15/2022	751	0.0%	10,497	6/30/2022
2022 Q1	5/16/2022	1,094	0.0%	11,149	3/31/2022
2021 Q4	2/14/2022	1,110	0.0%	13,110	12/31/2021
2021 Q3	11/15/2021	629	0.0%	7,873	9/30/2021
2021 Q2	8/16/2021	751	0.0%	7,699	6/30/2021
2021 Q1	7/20/2021	43	0.0%	367	3/31/2021
2020 Q4	2/16/2021	16	0.0%	144	12/31/2020
2020 Q3	11/16/2020	15	0.0%	126	9/30/2020
2020 Q2	8/14/2020	7	0.0%	61	6/30/2020
2020 Q1	6/16/2020	6	0.0%	90	3/31/2020
2019 Q4	2/14/2020	33	0.0%	355	12/31/2019